Ebola and Marburg Infections Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024
- 9Dimen Research
Ebola and Marburg Infections Market: Overview
Ebola and Marburg infection is a type of hemorrhagic fever that affects multiple organs of the body and leads to severe illness. These two viruses are native to Africa where intermittent outbreaks of these infections have occurred for decades. Ebola and Marburg viruses live in animal hosts and humans get affected when they come in contact with that infected animal. After this initial transmission the viruses can spread from person to person through contact with contaminated needles and body fluids.
According to World Health Organization (WHO), Marburg and Ebola viruses are the two members of Filoviridae family (filovirus). Though caused by different viruses, the two diseases are clinically similar. Both diseases are rare and have the capacity to cause dramatic outbreaks with high fatality rates. The early sign and symptoms of these infections include fever, joint and muscle aches, severe headache, chills, weakness and sore throat. While in severe conditions major symptoms observed are nausea, vomiting, diarrhea, chest pain and cough, stomach pain and excessive bleeding from the mouth, nose, ears, rectum and eye. The transmission of these viruses from animals was observed due to exposure of humans to infected animals body fluids. Transmission can happen through blood i.e. butchering or consuming infected animals can spread the virus while some of the veterinarians and scientists have also acquired this virus while operating any infected animal. Transmission through waste products of infected animals was observed in tourists visiting some African caves and also in mine workers that work underground possibly gets affected with Marburg virus. The high prevalence of Ebola and Marburg infection transmission from human to human was observed mostly in family members and doctors providing assistance especially witnessed in remote parts of Africa.
The diagnosis of Ebola and Marburg infections is complex as the initial symptoms observed in patients are same as for other infections such as typhoid and malaria. In infected individuals high concentration of Ebola and Marburg virus is found in the blood which is analyzed in laboratories by carrying out enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase polymerase chain reaction (PCR). There is currently no drug treatment for Ebola and Marburg infections hence the treatment consists of supportive hospital care including fluids, adequate blood pressure maintenance, replacing blood loss and treating any other infections that develop.
Ebola and Marburg Infections Market: Key Growth Enablers
The major drivers of Ebola and Marburg infections are high awareness and initiated government program in Africa, high research and development investments in diagnostic and treatment studies and government and NGOs support for the market players to research effective treatment. The major restraint of this market is, infections are geography specific and are found in North-East Africa and Philippines very rare cases were observed apart from these regions. The regions those are more prone to Ebola and Marburg infections from Africa are Gabon, Congo, South Sudan, Uganda, Kenya and Angola.
The drugs under pipeline are RC-EBODNA023-00-VP Vaccine + VRC-MARDNA025-00-VP Vaccine (National Institute of Allergy and Infectious Diseases), ST-383 (SIGA Technologies Inc), Vaccine for Filovirus (Crucell N.V), Polyvalent DNA Vaccine (Inovio Pharmaceuticals, Inc.), MVA-BN-Filoviruses Vaccine (Bavarian Nordic A/S), Monoclonal Antibody to Inhibit Glycoprotein for Marburg Virus Infection, TKM-Ebola (Tekmira Pharmaceuticals) are among others.
Ebola and Marburg Infections Market: Key Players
Most of the players of this market that are investing currently in R&D to come up with an effective treatment against Ebola and Marburg infections such as SIGA Technologies Inc., Bavarian Nordic A/S, NanoViricides, Inc., AlphaVax, Inc., Crucell N.V., Functional Genetics, Inc., Okairos AG, Immunovaccine, Inc., Inovio Pharmaceuticals, Inc. and Mapp Biopharmaceutical, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.
The study is a source of reliable data on:
- Key market segments and sub-segments
- Evolving market trends and dynamics
- Changing supply and demand scenarios
- Quantifying market opportunities through market sizing and market forecasting
- Tracking current trends/opportunities/challenges
- Competitive insights
- Opportunity mapping in terms of technological breakthroughs
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
TMR estimates the market size of various sectors using a combination of available data on the number and revenue of companies within each sub-sector and tiers of companies. The basic components used to determine market size and forecast for a specific product area are not only limited to supply-side data, but are also related to demand, industry trends, and the economic outlook. All the above data points are utilized to generate a statistical model targeting the sector marketplace. More than 300 TMR analysts across the world integrate these elements into a framework to determine the subsector market size for a base year and then forecast growth within each market.
TMR regularly interviews technology and business professionals as an ongoing effort to track the latest developments within each sector. These continuous surveys are stratified by company size and industry segment and weighted to reflect the global market place. All data are collected on an ongoing effort through a structured questionnaire rolled over the web or conducted via telephones. This provides the TMR team opportunities to request for detailed question sets, complex skip patterns, and real-time calculations, which assists respondents in answering questions involving numbers and percentages. Respondents, who are interviewed as experts, are screened and qualified based on certain criteria in addition to their decision-making authority and the scope of activity within their organizations.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017